Abstract
Although the evidence supporting the efficacy of neuroprotective treatments for hypoxic-ischemic injury in human newborns is limited, efforts to develop effective treatments continue in laboratory studies. In this article, we review some of the treatments that have found their way from the laboratory to clinical studies in newborns. Specifically, the evidence for use of magnesium sulfate, allopurinol, opioids, and hypothermia as possible treatments of hypoxic-ischemic encephalopathy are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
